Evidence map›Paper›PMID 39604214›Full record

ArticleCancer science2025

Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores.

Yudai Ishikawa, Hirotaka Fukue, Runa Iwakami, Masanori Ikeda, Kenji Iemura, Kozo Tanaka

Abstract read
In one paragraph

Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The kinetochore corona orchestrates chromosome congression through transient microtubule interactions.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yudai IshikawaDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.
Hirotaka FukueDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.
Runa IwakamiDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.
Masanori IkedaDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.
Kenji IemuraDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.ORCID https://orcid.org/0000-0003-0829-5299
Kozo TanakaDepartment of Molecular Oncology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.ORCID https://orcid.org/0000-0001-6086-2858

Funding

Japan Science and Technology Agency JPMJAX2112Japan Society for the Promotion of Science 15H04368Japan Society for the Promotion of Science 16H06635Japan Society for the Promotion of Science 16K14604Japan Society for the Promotion of Science 18H02434Japan Society for the Promotion of Science 18K15234Japan Society for the Promotion of Science 22H02614Japan Society for the Promotion of Science 23K05629Ministry of Education, Culture, Sports, Science and Technology 18H04896Ministry of Education, Culture, Sports, Science and Technology 21H05738Ministry of Education, Culture, Sports, Science and Technology 23H04272Mochida Memorial Foundation for Medical and Pharmaceutical ResearchTakeda Science FoundationThe Pharmacological Research Foundation. TokyoYamaguchi Educational and Scholarship Foundation
6 · The paper itself

Abstract

Most cancer cells show increased chromosome missegregation, known as chromosomal instability (CIN), which promotes cancer progression and drug resistance. The underlying causes of CIN in cancer cells are not fully understood. Here we found that breast cancer cell lines show a reduced kinetochore localization of ROD, ZW10, and Zwilch, components of the fibrous corona, compared with non-transformed breast epithelial cell lines. The fibrous corona is a structure formed on kinetochores before their end-on attachment to microtubules and plays a role in efficient kinetochore capture and the spindle assembly checkpoint. The reduction in the fibrous corona was not due to reduced expression levels of the fibrous corona components or to a reduction in outer kinetochore components. Kinetochore localization of Bub1 and CENP-E, which play a role in the recruitment of the fibrous corona to kinetochores, was reduced in cancer cell lines, presumably due to reduced activity of Mps1, which is required for their recruitment to kinetochores through phosphorylating KNL1. Increasing kinetochore localization of Bub1 and CENP-E in cancer cells restored the level of the fibrous corona. Cancer cell lines showed a reduced capacity to nucleate microtubules from kinetochores, which was recently shown to be dependent on the fibrous corona, and increasing kinetochore localization of Bub1 and CENP-E restored the microtubule nucleation capacity on kinetochores. Our study revealed a distinct feature of cancer cell lines that may be related to CIN.

Indexed as

Breast NeoplasmsKinetochoresMicrotubulesCell Cycle ProteinsCell Line, TumorChromosomal InstabilityChromosomal Proteins, Non-HistoneFemaleHumansIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesBUB1 protein, humanBub1 spindle checkpoint proteinCell Cycle Proteinscentromere protein EChromosomal Proteins, Non-HistoneIntracellular Signaling Peptides and ProteinsKnl1 protein, humanMicrotubule-Associated ProteinsNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTTK protein, humanZWINT protein, humanbreast cancerBub1CENP‐Echromosomal instabilityfibrous coronaRZZ complex

Identifiers

PMID39604214
PMCPMC11786318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.